These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 18756283)

  • 1. Photodynamic therapy with verteporfin for polypoidal choroidal vasculopathy.
    Lee MW; Yeo I; Wong D; Ang CL
    Eye (Lond); 2009 Jun; 23(6):1417-22. PubMed ID: 18756283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polypoidal choroidal vasculopathy and photodynamic therapy with verteporfin.
    Silva RM; Figueira J; Cachulo ML; Duarte L; Faria de Abreu JR; Cunha-Vaz JG
    Graefes Arch Clin Exp Ophthalmol; 2005 Oct; 243(10):973-9. PubMed ID: 15864616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series.
    Chan WM; Lam DS; Lai TY; Liu DT; Li KK; Yao Y; Wong TH
    Ophthalmology; 2004 Aug; 111(8):1576-84. PubMed ID: 15288991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined photodynamic therapy with verteporfin and intravitreal bevacizumab for polypoidal choroidal vasculopathy.
    Sato T; Kishi S; Matsumoto H; Mukai R
    Am J Ophthalmol; 2010 Jun; 149(6):947-954.e1. PubMed ID: 20346441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photodynamic therapy with verteporfin in polypoidal choroidal vasculopathy: results after 3 years of follow-up.
    Leal S; Silva R; Figueira J; Cachulo ML; Pires I; de Abreu JR; Cunha-Vaz JG
    Retina; 2010 Sep; 30(8):1197-205. PubMed ID: 20827139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photodynamic therapy with or without intravitreal triamcinolone acetonide for symptomatic polypoidal choroidal vasculopathy.
    Lai TY; Lam CP; Luk FO; Chan RP; Chan WM; Liu DT; Lam DS
    J Ocul Pharmacol Ther; 2010 Feb; 26(1):91-5. PubMed ID: 20148658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extensive submacular haemorrhage in polypoidal choroidal vasculopathy managed by sequential gas displacement and photodynamic therapy: a pilot study of one-year follow up.
    Chan WM; Liu DT; Lai TY; Li H; Tong JP; Lam DS
    Clin Exp Ophthalmol; 2005 Dec; 33(6):611-8. PubMed ID: 16402954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One-year outcomes of photodynamic therapy in age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients.
    Gomi F; Ohji M; Sayanagi K; Sawa M; Sakaguchi H; Oshima Y; Ikuno Y; Tano Y
    Ophthalmology; 2008 Jan; 115(1):141-6. PubMed ID: 17582498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Photodynamic therapy with verteporfin for polypoidal choroidal vasculopathy: long-term results].
    Saito M; Nagayama D; Iida T
    Nippon Ganka Gakkai Zasshi; 2009 Aug; 113(8):792-9. PubMed ID: 19715154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of photodynamic therapy in polypoidal choroidal vasculopathy.
    Akaza E; Yuzawa M; Matsumoto Y; Kashiwakura S; Fujita K; Mori R
    Jpn J Ophthalmol; 2007; 51(4):270-7. PubMed ID: 17660987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-year results of reduced-fluence photodynamic therapy for polypoidal choroidal vasculopathy.
    Yamashita A; Shiraga F; Shiragami C; Ono A; Tenkumo K
    Am J Ophthalmol; 2010 Mar; 149(3):465-71.e1. PubMed ID: 20042180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marked vascular changes of polypoidal choroidal vasculopathy after photodynamic therapy.
    Wakabayashi T; Gomi F; Sawa M; Tsujikawa M; Tano Y
    Br J Ophthalmol; 2008 Jul; 92(7):936-40. PubMed ID: 18577645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Five-year follow-up results of photodynamic therapy for polypoidal choroidal vasculopathy.
    Kang HM; Kim YM; Koh HJ
    Am J Ophthalmol; 2013 Mar; 155(3):438-447.e1. PubMed ID: 23218705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Photodynamic therapy for polypoidal choroidal vasculopathy].
    You J; Guo X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Sep; 36(9):899-902. PubMed ID: 21946209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-year results of reduced-fluence photodynamic therapy for polypoidal choroidal vasculopathy.
    Yamashita A; Shiraga F; Shiragami C; Shirakata Y; Fujiwara A
    Am J Ophthalmol; 2013 Jan; 155(1):96-102.e1. PubMed ID: 22995028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term results of photodynamic therapy of polypoidal choroidal vasculopathy.
    Akaza E; Mori R; Yuzawa M
    Retina; 2008 May; 28(5):717-22. PubMed ID: 18463515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central retinal sensitivity measured with the micro perimeter 1 after photodynamic therapy for polypoidal choroidal vasculopathy.
    Yodoi Y; Tsujikawa A; Kameda T; Otani A; Tamura H; Mandai M; Yoshimura N
    Am J Ophthalmol; 2007 Jun; 143(6):984-994. PubMed ID: 17336913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up of polypoidal choroidal vasculopathy after photodynamic therapy with verteporfin.
    Sayanagi K; Gomi F; Sawa M; Ohji M; Tano Y
    Graefes Arch Clin Exp Ophthalmol; 2007 Oct; 245(10):1569-71. PubMed ID: 17437122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective photodynamic therapy for neovascular age-related macular degeneration with polypoidal choroidal neovascularization.
    Eandi CM; Ober MD; Freund KB; Slakter JS; Yannuzzi LA
    Retina; 2007 Sep; 27(7):825-31. PubMed ID: 17891004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photodynamic therapy with verteporfin in the treatment of exudative idiopathic polypoidal choroidal vasculopathy.
    Mauget-Faÿsse M; Quaranta-El Maftouhi M; De La Marnièrre E; Leys A
    Eur J Ophthalmol; 2006; 16(5):695-704. PubMed ID: 17061220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.